SpliSense is currently conducting a Phase IIb trial with its antisense oligonucleotide therapy.
SpliSense, a clinical-stage biotechnology company developing transformative RNA-based therapies for pulmonary diseases, today announced that it has entered into a funding agreement with the Cystic ...
האתר עושה שימוש בעוגיות (Cookies) לצורך שיפור חוויית המשתמש, ניתוח נתוני גלישה והתאמת תכנים אישית. המשך הגלישה באתר מהווה ...
BETHESDA, Md., June 03, 2026 (GLOBE NEWSWIRE) -- Today, the Cystic Fibrosis Foundation announced that Heather Culp will join ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Cystic fibrosis, or CF, is a lifelong genetic condition that affects how the body produces mucus, sweat, and digestive fluids. More than 100,000 people across 94 countries have been diagnosed with ...
With this year's football game kicking off at 7 Friday night, we're taking a look at the organization and its mission for ...
BETHESDA, Md.--(BUSINESS WIRE)--The Cystic Fibrosis Foundation today announced the recipients of its eighth annual Impact Grants, a program which provides up to $10,000 in funding annually for up to ...
BETHESDA, Md.--(BUSINESS WIRE)--The Cystic Fibrosis Foundation today announced its investment of $6 million in Carbon Biosciences to support the company‘s preclinical research into an innovative gene ...
NETWORK. CYSTIC FIBROSIS IS A DISEASE THAT IMPACTS THOUSANDS OF PEOPLE HERE IN THE U.S. ONE FOUNDATION BRINGING AWARENESS OF THE DISEASE THROUGHOUT THE METRO. JOINING ME TODAY IS SHELBY AND RACHEL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results